BioNTech CEO Ugur Sahin said Friday that while there were concerns the Pfizer-BioNTech vaccine may not be as effective against the new Omicron COVID-19 variant, it was possible to quickly adapt the current shot to combat the variant.
COVID-19
COVID-19: BioNTech CEO says it’s possible to quickly adapt Pfizer vaccine for Omicron
More Videos
-
Health Matters: COVID-19 vaccine can offer protection in pregnancy, new study finds
-
Health Matters: Rising measles cases being fueled in part by vaccine hesitancy around the world, study shows
-
Health Matters: COVID-19 vaccine may help cancer treatments, study finds
-
‘Freedom Convoy’ leaders Tamara Lich, Chris Barber sentenced 12 months house arrest, 6 months curfew
-
Health Matters: Obesity on the rise among Canadian adults
-
Quebec joins Alberta in ending free COVID-19 vaccines for some people
You are viewing an Accelerated Mobile Webpage.
View Original Article